70
Participants
Start Date
April 17, 2017
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
ipilimumab
ipilimumab 3mg/kg
nivolumab
nivolumab 1mg/kg
Hospital for Special Surgery (Data Analysis), New York
Columbia University (Data Analysis Only), New York
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Nassau, Uniondale
Memorial Sloan Kettering Commack, Commack
Lehigh Valley Health Network (Data Collection Only), Allentown
JOHNS HOPKINS HOSPITAL (Data Analysis Only), Baltimore
Hartford Healthcare Alliance (Data Collection Only), Hartford
Jaykumar Thumar, Hartford
Brigham and Women's Hospital (Data and Specimen Analysis Only), Boston
Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER